Source: International Congress 2019 – Biology and prognosis of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Tang (BARCELONA, Spain), J. Yelamos (BARCELONA, Spain), C. Ampurdanes (BARCELONA, Spain), A. Salazar-Degracia (BARCELONA, Spain), X. Wang (BARCELONA, Spain), L. Pijuan (BARCELONA, Spain), V. Curull (BARCELONA, Spain), E. Barreiro Portela (BARCELONA, Spain). Expression of PARP in lung cancer: Patients with COPD and mice. 3061

Member's Comments

No comment yet.

Related content which might interest you: Expression of PD1, COPD and lung cancer. Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002 Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005 Lung cancer in COPD patients Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Expression of apoptotic markers in lung tissue of COPD patients: preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Lung cancer screening in COPD patients. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Pecularities of lung cancer in patients with COPD Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Airway gene expression as a link between COPD and lung cancer Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009